Health Care Equity Act Moves Forward

Summary#

Bill 233, the Improving Access to Health Care Act, 2020, would amend four Ontario laws: the Anti-Racism Act, 2017, the Connecting Care Act, 2019, the Local Health System Integration Act, 2006 and the Public Hospitals Act. Its stated goal is to put recommendations in a provincial handbook on sickle cell disease into effect and support more equitable care; the bill does not guarantee those results.

  • The Minister of Health would have to issue directives, provincial standards and hospital directives needed to implement the handbook’s recommendations.
  • The Minister would have to arrange reviews of whether health care funding is sufficient for patients with sickle cell disease and communities affected by it. The reviews must include consultation with patient advocacy groups.
  • The first funding review would be due within a year after the Act comes into force; later reviews would be due within five years after the previous review is completed.
  • The Ministry of Health, Ministry of Long-Term Care, Ontario Health and any Ontario-funded person providing health care would have to take all reasonable steps to ensure information about patients’ race is collected. The bill deems necessary personal information to be included in data standards and the collection to be required by regulations, unless already covered.
  • The bill would repeal part of the Anti-Racism Act, 2017. Without that Act’s text, its effect cannot be verified.

What it means for you#

  • People with sickle cell disease: The bill would require government directions and standards aimed at implementing the handbook. It would also require reviews of whether funding is sufficient. It does not create a direct right to a particular treatment, amount of funding or health outcome.
  • Hospitals and other Ontario-funded health care providers: They would be subject to the applicable directives or standards. Providers receiving government funding would also have to take all reasonable steps to ensure race information is collected.
  • Patients generally: Their race information would be collected under the bill’s requirement. The bill does not set out details such as how long information is kept or who can access it.
  • Patient advocacy groups: They must be consulted as part of each funding review.
  • Taxpayers: The bill requires government and providers to carry out these duties, but does not say how much they will cost.

Money#

No publicly available information on the bill’s estimated costs.

  • The bill requires directives, standards, funding reviews and steps to collect race information, but gives no cost estimate, staffing figure or specific appropriation.
  • It does not set a new fee, tax, fine or benefit.

What is unclear#

  • The handbook’s recommendations are not included in the supplied material, so their specific requirements cannot be described.
  • The bill does not define “all reasonable steps” or explain how reviews will assess whether funding is sufficient.
  • It sets review deadlines and requires consultation, but does not specify who conducts the reviews, how findings are reported or what action must follow.
  • The bill does not set out privacy, access or retention rules for race information. Existing rules may address some of these matters, but the relevant Act and regulations were not supplied.
  • Without the parent Acts, the current law and the effect of repealing part of the Anti-Racism Act, 2017 cannot be verified.

Case for#

  • The bill appears intended to address inconsistent care for people with sickle cell disease by requiring provincial standards and directives based on a named clinical handbook.
  • Required reviews could identify whether funding is sufficient for patients and affected communities.
  • Requiring patient advocacy groups to be consulted gives them a formal role in those reviews.
  • Collecting information about race could help health authorities examine care across patient groups, though the bill does not guarantee a particular result.

Case against#

  • The bill requires instruments to implement handbook recommendations without including the recommendations themselves, so the practical changes are not clear from this text.
  • It requires funding reviews but does not require more funding or specify what happens if a review finds a shortfall.
  • The race-information requirement could involve sensitive personal information, while the bill itself does not spell out privacy safeguards.
  • The bill requires several government and health-system bodies to act, but gives no cost estimate, staffing plan or detailed process.